Global spinal cord peptidome profiling in response to osteoarthritis in rats
Molecular Omics · 2025
DOI: 10.1039/d5mo00152h ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Omics, 2025. Verfasst von Gaoyuan Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA. lingjun.li@wisc.edu. Hauptthemen laut MEDLINE: Spinal Cord, Osteoarthritis, Neuropeptides, Proteome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
Osteoarthritis (OA) is a complex and increasingly prevalent condition, affecting an estimated 600 million people worldwide and significantly reducing quality of life. Understanding OA as both an inflammatory and neurological disease presents challenges for diagnosis and treatment, as no curative therapy is currently available. The neuroactive effects of OA pain on neuropeptide systems, particularly within the spinal cord, remain underexplored, impeding therapeutic advances. Mass spectrometry (MS) was employed to characterize the spinal cord peptidome in a validated rat model of OA pain. The peptidome was analyzed longitudinally over 84 days using the Montreal Induction of Rat Arthritis Testing (MI-RAT©; n = 20) model, compared to arthrotomic (Sham; n = 4) and healthy (Naive; n = 9) groups. Label-free peptidome profiling using liquid chromatography coupled with tandem MS (LC-MS/MS) revealed dynamic changes in endogenous spinal peptides during OA progression, leading to the identification of 624 peptides derived from 29 prohormone precursors. The findings reveal substantial changes in peptide levels in the spinal cord, particularly involving neuropeptide substance P and peptides derived from proenkephalin, calcitonin gene-related peptide, and somatostatin. These results provide novel insights into the molecular mechanisms underlying OA-associated pain and identify potential targets for new therapeutic interventions in neurological pain conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA. lingjun.li@wisc.edu.
- Groupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Université de Montréal, Saint-Hyacinthe, QC J2S 2M2, Canada. eric.troncy@umontreal.ca.
- Osteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Montréal, QC H2X 0A9, Canada.
- Department of Pathology and Microbiology, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, QC J2S 2M2, Canada.
- Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
- Lachman Institute for Pharmaceutical Development, School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.
Förderung
- NIA NIH HHS
- NIH HHS
- NCRR NIH HHS
- NIDA NIH HHS
- NIDDK NIH HHS
- National Science Foundation
- National Institutes of Health
- Wisconsin Alumni Research Foundation
Zitieren
APA
Lu, G., Frézier, M., Otis, C., Tran, V. N. H., Lussier, B., Saint-Jean, G., Beaudry, H., Troncy, E., & Li, L. (2025). Global spinal cord peptidome profiling in response to osteoarthritis in rats. Molecular Omics. https://doi.org/10.1039/d5mo00152h
Vancouver
Lu G, Frézier M, Otis C, Tran VNH, Lussier B, Saint-Jean G, et al. Global spinal cord peptidome profiling in response to osteoarthritis in rats. Molecular Omics. 2025. doi:10.1039/d5mo00152h
BibTeX
@article{Lu2025,
author = {Lu, Gaoyuan and Frézier, Marilyn and Otis, Colombe and Tran, Vu Ngoc Huong and Lussier, Bertrand and Saint-Jean, Guillaume and Beaudry, Helene and Troncy, Eric and Li, Lingjun},
title = {Global spinal cord peptidome profiling in response to osteoarthritis in rats},
journal = {Molecular Omics},
year = {2025},
doi = {10.1039/d5mo00152h}
}
EUVIMED